Description

Cinepazic Acid CAS NO 54063-23-9 is a high-purity pharmaceutical intermediate and research chemical of significant importance in modern medicinal chemistry. Its primary value lies in its role as a key synthetic precursor for the development of novel therapeutic agents, particularly in the cardiovascular and anti-inflammatory domains. This compound is essential for pharmaceutical R&D laboratories, advanced chemical synthesis facilities, and manufacturers of active pharmaceutical ingredients (APIs) seeking reliable and consistent raw materials.

Application

• Pharmaceutical Intermediate: A critical building block in the multi-step synthesis of complex drug molecules and novel chemical entities.
• Cardiovascular Drug Research: Used in the development and study of potential therapeutic agents targeting heart-related conditions.
• Anti-inflammatory Agent Synthesis: Serves as a precursor in the creation of compounds with potential anti-inflammatory properties.
• Medicinal Chemistry & Lead Optimization: Employed by research chemists for structure-activity relationship (SAR) studies and lead compound modification.
• Active Pharmaceutical Ingredient (API) Manufacturing: Integrated into GMP-compliant production processes for final drug substances.
• Biochemical Research: Utilized in studies investigating biological pathways and mechanisms at the molecular level.
• Reference Standard: Serves as a high-purity analytical standard for quality control and method validation in pharmaceutical analysis.

Basic Information

Product Name	Cinepazic Acid
CAS No.	54063-23-9
Molecular Formula	C20H28N2O5
Molecular Weight	376.45 g/mol
Synonyms	1-[2-(3,4,5-Trimethoxyphenyl)ethyl]-4-piperidinecarboxylic Acid; Cinepazic Acid; Cinepazate; MDL 725; EGYT 341; EGYT-341; EGYT341; (1-[2-(3,4,5-Trimethoxyphenyl)ethyl]piperidin-4-yl)carboxylic Acid
EINECS	Contact for details

Quality Control

Our Cinepazic Acid is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity. Each lot undergoes comprehensive analytical testing, including identification, assay, and impurity profiling, to meet the stringent requirements of pharmaceutical development and manufacturing. Certificates of Analysis (COA) detailing all test results are provided and can be tailored to meet specific customer or regulatory standards (e.g., ICH guidelines).

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed after each use to minimize exposure to atmospheric moisture. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥98.0%
Loss on Drying	≤1.0%
Residue on Ignition	≤0.1%
Related Substances (HPLC)	Total impurities ≤2.0% Any single impurity ≤0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.